|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.02 USD | +0.06% |
|
+0.17% | -2.60% |
| Market Cap | 4.45B 3.9B 3.61B 3.33B 6.31B 426B 6.44B 43.34B 16.84B 209B 16.72B 16.35B 724B | P/E 2026 * |
67.7x | P/E 2027 * | 35.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.49B 3.06B 2.82B 2.61B 4.95B 334B 5.05B 33.95B 13.19B 163B 13.1B 12.81B 567B | EV / Sales 2026 * |
2.81x | EV / Sales 2027 * | 2.35x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACADIA Pharmaceuticals Inc.
| 1 day | +0.06% | ||
| 1 week | +0.17% | ||
| Current month | +2.83% | ||
| 1 month | +19.12% | ||
| 3 months | +15.26% | ||
| 6 months | -2.86% | ||
| Current year | -2.60% |
| 1 week | 25.24 |  | 26.37 |
| 1 month | 20.84 | | 27.31 |
| Current year | 19.89 | | 27.81 |
| 1 year | 19.69 | | 28.35 |
| 3 years | 13.4 | | 33.99 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 20/09/2024 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 10/09/2021 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 01/05/2008 |
Stephen Biggar
CHM | Chairman | 55 | 10/06/2016 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 25/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-26 | Sell | Controller/Auditor | -11,421 | 0.0067% | ||
| 05-29 | Fiscal year | Director | 41,529 | 0.0243% | ||
| 05-29 | Fiscal year | Director | 41,529 | 0.0243% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | +0.17% | +20.61% | +5.03% | 4.45B | |
| +1.68% | +3.19% | +3.55% | +10.22% | 49.42B | |
| +1.24% | +1.70% | +399.65% | +607.33% | 40.34B | |
| +1.94% | +0.39% | +28.29% | -5.28% | 34.01B | |
| +1.16% | +2.27% | +19.05% | +58.11% | 33.56B | |
| -2.09% | -0.80% | +3.56% | +33.56% | 26.84B | |
| +1.18% | +2.38% | - | - | 17.22B | |
| +0.27% | -4.27% | +66.32% | +120.78% | 15.19B | |
| -22.84% | -19.30% | +54.12% | +57.99% | 13.96B | |
| +2.59% | -0.49% | +15.24% | +20.83% | 13.36B | |
| Average | -1.49% | +1.06% | +67.82% | +100.95% | 24.84B | |
| Weighted average by Cap. | -0.33% | +0.94% | +86.76% | +132.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.24B 1.09B 1B 928M 1.76B 119B 1.8B 12.08B 4.69B 58.14B 4.66B 4.56B 202B | 1.4B 1.22B 1.13B 1.04B 1.98B 134B 2.02B 13.58B 5.28B 65.38B 5.24B 5.12B 227B |
| Net income | 65.75M 57.67M 53.24M 49.2M 93.26M 6.3B 95.12M 640M 249M 3.08B 247M 242M 10.7B | 134M 117M 108M 100M 190M 12.81B 193M 1.3B 506M 6.27B 502M 491M 21.76B |
| Net Debt | -965M -846M -781M -722M -1.37B -92.36B -1.4B -9.39B -3.65B -45.2B -3.62B -3.54B -157B | -1.18B -1.03B -953M -881M -1.67B -113B -1.7B -11.46B -4.45B -55.16B -4.42B -4.32B -191B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | $26.02 | +0.06% | 396,548 |
| 08/07/26 | $26.00 | -0.76% | 1,551,853 |
| 07/07/26 | $26.20 | +1.67% | 1,674,460 |
| 06/07/26 | $25.77 | -0.77% | 1,155,022 |
| 02/07/26 | $25.97 | +3.06% | 1,586,395 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
